Malaysia expects Covid-19 vaccines to be used by the first quarter of 2021



[ad_1]

KUALA LUMPUR: Malaysia has high hopes of obtaining Covid-19 vaccines from producing countries, which are expected to be used by the first quarter of next year.

Minister of Health, Datuk Seri Dr. Adham Baba (pix) said that, according to the latest reports, there are now 10 top candidates among vaccine producers who have completed the third phase of their clinical trials in vaccine development.

“As reported to us, the vaccine produced by Pfizer Inc. and BioNTech SE has been claimed to be 90 percent effective. This is a good and healthy development.

“We are sure that there are many more prominent candidates in the world such as the Gamaleya Research Institute, whose vaccine has also undergone the third phase of clinical trials, which we also see as a good opportunity to provide vaccines to our own people.

“However, we do not yet know the results of the third phase clinical trials for the Chinese vaccine… we have not concluded our discussions yet.

“However, the acquisition of Covid-19 vaccines for our country will depend on careful considerations regarding the quality, safety, implications and registration of these vaccines by the producing countries,” he said during the ‘Selamat Pagi Malaysia’ program produced by Radio Televisyen Malaysia (RTM), today.

When asked if former Covid-19 patients could become infected again, Dr. Adham said the chances were low compared to those who had never been infected with the virus.

He said that the recovery rate, meanwhile, had shown increases with 73 percent recorded yesterday compared to 65 percent two weeks ago, which shows that the treatment protocols and the regimen implemented in hospitals and health centers of this country were in line with public health safety approaches.

On the increase in the number of positive Covid-19 cases in some states, federal territories and the Klang Valley, Dr. Adham said that these were linked to the workplace and groups of construction sites where the infectivity rates in these places were high as there was movement of people. and laxity in adhering to standard operating procedure (SOP).

“The increase in cases in Kuala Lumpur shows that we need to strengthen actions, compliance, enforcement and monitoring. We have to continue with preventive and control measures, adhere to the SOP and adapt to the new regulations.

“This is everyone’s responsibility. With regard to workplace groups, it is very important that employers and workers are accountable. Employers have a vital role in ensuring that their staff or workers are always protected, ”he added. – Called



[ad_2]